OFFER DEADLINE17/08/2018 16:30 - Europe/Brussels
EU RESEARCH FRAMEWORK PROGRAMMEH2020 / Marie Skłodowska-Curie Actions
ORGANISATION/COMPANYFundación Universidad Católica de Valencia San Vicente Mártir.
DEPARTMENTFaculty of Veterinary and Experimental Science
LABORATORYBioengineering and Cellular Therapy
IS THE HOSTING RELATED TO A PROJECT WITHIN A RESEARCH INFRASTRUCTURE?Yes
Valencia Catholic University Saint Vincent Martyr (UCV) is a young private university with 26 bachelor’s degrees, 58 masters and 24 research institutes. The UCV Group of Bioengineering and Cell Therapy is led by Professor Ángel Serrano-Aroca and there are researchers working in specific areas such as Biomaterials, Tissue Engineering, Bioreactors and Microbiology. Thus, the main research line of this group consists of making use of new technological advances such as 3D printing and nanomaterials with unique properties such as graphene and its derivatives, to develop new advanced materials for biomedical applications. The latest research results obtained exhibited a very promising future, since they have managed to develop new biodegradable materials reinforced with graphene with high antibacterial capacity. Professor Ángel Serrano's team actively collaborates with Dr. Victoria Moreno, principal investigator at the Prince Felipe Research Centre (CIPF), Professor Sanjukta Deb from King's College London, Professor Finn Aachmann from the Norwegian University of Science and Technology, Professor Roser Sabater from the Center for Biomaterials and Tissue Engineering and Dr. César David Vera from La Fe Hospital and Research Centre. The research activity is placed at Santa Úrsula located at the city center of Valencia, a monastery that has been renovated and expanded. It has a floor area of 5000 m2 and is equipped with modern technological laboratories to facilitate the proper use of academic and research university activities.
The rapid emergence of microbial resistance in pathogenic microorganisms such as bacteria, fungi, viruses, and parasites is becoming an imminent global public health problem, which is estimated ty the World Health Organization to surpass all other life threatening diseases including cancer in the year 2050. Therefore, the development of new alternative antimicrobial strategies is becoming more and more necessary. In this regard, nanotechnology has emerged as a relatively new therapeutic tool capable of dealing with microbial resistance and represents a promising alternative for the development of new advanced materials and compounds that could replace traditional antibiotics. In this regard, our research group is trying to develop new alternative antibacterials based on carbon nanomaterials such as graphene and its derivatives able to deal with multidrug-resistant bacteria. However, the toxicity of these compounds is not completely understood and the study of their interaction with mammalian cells become also essential.
Therefore, if you have a strong background in one or more of the following research areas: microbiology and/or cell culture and/or material science, do not hesitate to contact us for a possible MSCA-IF 2018 grant. If you do not have a good background in one or two of the mentioned research areas, do not worry because we are an interdisciplinary group with experts in each field and what we really need now is Postdocs with a strong background in at least one of the mentioned scientific backgrounds.
Applications : Documents to be submited
Candidates are required to submit a complete and updated CV and a motivation letter. Applications should be sent to: email@example.com with subject MSCA-IF 2018 CANDIDATE